Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort. - Wikidata - wikimedia - TriplyDB

Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort.

Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort.

http://www.wikidata.org/entity/Q34556277

about

Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinoma Liver transplantation for hepatocellular carcinoma beyond the Milan criteria Usefulness of staging systems and prognostic scores for hepatocellular carcinoma treatments Brazilian society of hepatology recommendations for the diagnosis and treatment of hepatocellular carcinoma Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system Overexpression of Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 5 (LGR5) Represents a Typical Wnt/β-Catenin Pathway-Activated Hepatocellular Carcinoma Emerging trends in hepatocellular carcinoma: focus on diagnosis and therapeutics Diagnostic and therapeutic management of hepatocellular carcinoma How grim is hepatocellular carcinoma?Treatment algorithms for managing hepatocellular carcinoma Application of radiotherapy for hepatocellular carcinoma in current clinical practice guidelines Update in management of hepatocellular carcinoma in Eastern population Comparison of hepatocellular carcinoma in Eastern versus Western populations.Cost-utility analysis of nonalcoholic steatohepatitis screening.Pretreatment assessment of hepatocellular carcinoma: expert consensus statement.Current management of hepatocellular carcinoma.How admissions to various medical specialty divisions determines the outcome of patients with hepatocellular carcinoma: results from a retrospective study in a large hospital of northwest China Extending survival with the use of targeted therapy in the treatment of hepatocellular carcinoma.Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a large case cohort study.Eastern Asian expert panel opinion: designing clinical trials of molecular targeted therapy for hepatocellular carcinoma Reassessing hepatocellular carcinoma staging in a changing patient population.Prognosis of patients with hepatocellular carcinoma and hypersplenism after surgery: a single-center experience from the People's Republic of China.Staging of biliary tract and primary liver tumors.Barcelona Clinic Liver Cancer outperforms Hong Kong Liver Cancer staging of hepatocellular carcinoma in multiethnic Asians: Real-world perspective.Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma.Prognostic role of noninvasive liver reserve markers in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.Prognosis evaluation in patients with hepatocellular carcinoma after hepatectomy: comparison of BCLC, TNM and Hangzhou criteria staging systems.International validation of the Chinese university prognostic index for staging of hepatocellular carcinoma: a joint United Kingdom and Hong Kong study An evidence-based multidisciplinary approach to the management of hepatocellular carcinoma (HCC): the Alberta HCC algorithm Disparities in hepatocellular carcinoma survival among Californians of Asian ancestry, 1988 to 2007.Epigenetic signatures of alcohol abuse and hepatitis infection during human hepatocarcinogenesis.Diagnostic performance of alpha-fetoprotein, lens culinaris agglutinin-reactive alpha-fetoprotein, des-gamma carboxyprothrombin, and glypican-3 for the detection of hepatocellular carcinoma: a systematic review and meta-analysis protocol.A re-emerging marker for prognosis in hepatocellular carcinoma: the add-value of fishing c-myc gene for early relapse Novel role for epidermal growth factor-like domain 7 in metastasis of human hepatocellular carcinoma.A new model to estimate prognosis in patients with hepatocellular carcinoma after Yttrium-90 radioembolization.Comparing staging systems for predicting prognosis and survival in patients with hepatocellular carcinoma in Egypt.Prognosis of unresectable hepatocellular carcinoma: comparison of seven staging systems (TNM, Okuda, BCLC, CLIP, CUPI, JIS, CIS) in a Chinese cohort.Level of α-fetoprotein predicts mortality among patients with hepatitis C-related hepatocellular carcinoma Polymorphisms in Genes of Tricarboxylic Acid Cycle Key Enzymes Are Associated with Early Recurrence of Hepatocellular Carcinoma.

P2860

Q24635267-C4C0FB3A-52CA-4B13-93DD-8CD240DBE50D Q24658550-C109220F-0C9F-4502-8FA2-3D34F9E0EA9A Q26743666-4142D56B-D42B-41B7-BEDB-A214540C1737 Q26766707-2ACA37C7-949F-44F7-9FF8-74B85DE9B912 Q26783881-1A0E3FC3-B4C2-4554-8B96-CDAC9182CE9A Q26784223-A04C1B43-2F48-4712-ACBE-A028E085B993 Q26797525-02AC8D5B-AB21-4DF2-BF04-B6EB13653FCF Q26851272-957C826C-D43C-4972-8644-680F7822D94D Q26999043-A7B60D03-A993-4DAF-B09E-6E0A81D8F85F Q27001669-0A5412E3-D989-4D2A-9BC1-A14A27D52DA4 Q27027923-31E35EA6-59FD-4303-8296-EB77B7AB49AC Q28076314-09A7FC53-6DE0-45BE-9E0A-3823066268E0 Q28080480-0CBD72BD-F626-4545-9EC0-AD84A62A11EF Q30245396-CE73B19B-81A0-4EAE-BCAE-0317FD43C4E1 Q30385602-FF5ECF94-D159-416D-AC2C-A12B09FA1413 Q30432108-7A8F7B5C-5B3E-4643-8C89-AEE56B864D16 Q33582165-BFB90408-8249-4CD6-AA7D-7FBF24F92AA6 Q33597474-6B41A889-B3EE-4E84-AEA3-299C93835231 Q33648955-E3EDCE0B-DF22-4F59-82AC-56693116D3C7 Q33718951-3A5BDDEA-BC2D-4D24-860E-D02255EAB530 Q33742856-3F8F23E9-B03B-4204-8824-112B3C941789 Q33767286-7BF03F67-468F-4989-AABF-F732F60124E6 Q33769497-8A73E068-D5C4-40C5-89E6-6E35D0391619 Q33773415-686E5C87-7B32-4D31-851D-78A0D0A0D810 Q33805894-DD9FE06A-676B-455A-BB70-BF168B0E2C13 Q33820376-4C7A2636-7528-47D3-81B1-FFBDF51B280D Q33865883-334B24AC-8674-43C3-A9CD-AFD6E49FCB3F Q34061430-500C766B-0E3E-43CC-9A05-6095A499A2AB Q34346779-26314B84-0502-4EC8-B35C-43DE593F09B3 Q34417009-5D4F1F0F-2569-4030-8C76-A27AEF3BD24E Q34470706-C14BFA2B-6845-438A-8ECA-408C6A50C88B Q34619389-CD54B231-1555-422D-894D-3D391859467A Q34759365-E6D9D3F4-CA78-4896-B739-E711862E8CFD Q34847309-D7992B22-997B-4CBC-8308-BF772E44DC40 Q35007692-3B2DDF82-9A02-4ED4-925C-BD39B5C64E2D Q35075280-6F168CA0-1865-495D-8835-8098FD7AF883 Q35113002-0C6AB237-302F-4229-8E4F-8A07876451B7 Q35114970-92E5402A-538D-4695-80E1-D1C337F1FFB4 Q35435112-3726FF66-36D6-4A63-B8E8-29B4CF35AB04 Q35500621-20380A17-E242-40CB-A7C0-A636BEB4D8F6

P2860

Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort.

http://www.wikidata.org/entity/Q34556277

description

2005 nî lūn-bûn

@nan

2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Prognosis of hepatocellular ca ...... systems in an American cohort.

@ast

Prognosis of hepatocellular ca ...... systems in an American cohort.

@en

Prognosis of hepatocellular ca ...... systems in an American cohort.

@nl

type

label

Prognosis of hepatocellular ca ...... systems in an American cohort.

@ast

Prognosis of hepatocellular ca ...... systems in an American cohort.

@en

Prognosis of hepatocellular ca ...... systems in an American cohort.

@nl

prefLabel

Prognosis of hepatocellular ca ...... systems in an American cohort.

@ast

Prognosis of hepatocellular ca ...... systems in an American cohort.

@en

Prognosis of hepatocellular ca ...... systems in an American cohort.

@nl

P1433

Q34556277-FA55EC0C-01F1-4059-B441-0FDEDCD145E6

P1476

Q34556277-5BD4533E-33DC-4B23-ACCC-490A7D3D23AB

P2093

Q34556277-52967FD8-3052-4FC1-8D3C-55C428412DF2

Q34556277-7610A78C-C23C-4462-8997-D3E31C466F99

Q34556277-7E9F5483-F4FD-4F31-A385-C04F7DE7F4E3

Q34556277-C5659CB6-BBEB-4667-8619-A2703E43F4BE

Q34556277-DD0E12C5-534A-4194-9C22-243F5F0EF1C6

Q34556277-DFA4F1FD-CCEA-448B-AD29-59D44C2437C9

Q34556277-FDAA02C5-479D-4734-9031-FD984BFC7908

P2860

Q34556277-6EBAE0FD-5191-46F0-BA88-0ED7D0A3B8FC

Q34556277-A867569E-9894-469F-8A6F-8E05036D756D

Q34556277-DE65A782-5DE6-4266-8F5E-D5509563878D

P304

Q34556277-E4D4FAA2-9947-40C0-AFD5-D637252BB392

P31

Q34556277-8E8467CF-9C6C-4C9C-AD3C-6683E17AA371

P356

Q34556277-D62F94B1-413F-4AE1-96E2-2AA94F209420

P407

Q34556277-C4BF6C44-54EF-4DDB-AECA-6C66974C34D1

P433

Q34556277-90A8AB21-6B61-4CD5-9EE8-E942E28A517D

P478

Q34556277-BAA86988-6C55-4960-9516-0D0D268EA2DE

P577

Q34556277-A7D19E90-C898-4A32-B248-9668B6CD18D3

P5875

Q34556277-ADFB389D-F903-4F43-A869-5096E50A7A86

P698

Q34556277-38DD458D-1596-49D3-9602-6EEC5D1AC2FB

P356

P1433

P1476

Prognosis of hepatocellular ca ...... systems in an American cohort.

@en

P2093

Anna S Lok

http://www.w3.org/2001/XMLSchema#string

Ashley Barrat

http://www.w3.org/2001/XMLSchema#string

Frederick Askari

http://www.w3.org/2001/XMLSchema#string

Grace L Su

http://www.w3.org/2001/XMLSchema#string

Hari S Conjeevaram

http://www.w3.org/2001/XMLSchema#string

Jorge A Marrero

http://www.w3.org/2001/XMLSchema#string

Robert J Fontana

http://www.w3.org/2001/XMLSchema#string

P2860

Transjugular intrahepatic portosystemic shunt for palliative treatment of portal hypertension secondary to portal vein tumor thrombosis

AHPBA/AJCC consensus conference on staging of hepatocellular carcinoma: consensus statement.

Clinical biostatistics. XVI. The process of prognostic stratification. 2.

P304

707-716

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.20636

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P577

2005-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7939855

http://www.w3.org/2001/XMLSchema#string

P698

15795889

http://www.w3.org/2001/XMLSchema#string